Total Payments
$6,186
2024 Payments
$2,829
Companies
58
Transactions
282
Medicare Patients
264
Medicare Billing
$19,332
Payment Breakdown by Category
Food & Beverage$5,986 (96.8%)
Education$199.98 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,986 | 280 | 96.8% |
| Education | $199.98 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $548.49 | 18 | $0 (2024) |
| Incyte Corporation | $419.14 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $418.01 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $412.66 | 15 | $0 (2024) |
| Astellas Pharma US Inc | $317.64 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $280.00 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $264.22 | 13 | $0 (2024) |
| GENZYME CORPORATION | $231.52 | 12 | $0 (2024) |
| PFIZER INC. | $216.31 | 14 | $0 (2024) |
| Exelixis Inc. | $172.16 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,829 | 132 | E.R. Squibb & Sons, L.L.C. ($202.97) |
| 2023 | $1,639 | 76 | Astellas Pharma US Inc ($243.25) |
| 2022 | $656.77 | 25 | Janssen Biotech, Inc. ($174.67) |
| 2021 | $1,001 | 45 | AstraZeneca Pharmaceuticals LP ($261.27) |
| 2020 | $14.02 | 1 | PFIZER INC. ($14.02) |
| 2019 | $13.48 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.48) |
| 2018 | $14.30 | 1 | Merck Sharp & Dohme Corporation ($14.30) |
| 2017 | $19.25 | 1 | Shire North American Group Inc ($19.25) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.98 | General |
| 12/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Rare Disease | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/11/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: BioOncology | ||||||
| 10/22/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: Hematology/Oncology | ||||||
| 10/18/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 264 | 1,055 | $61,671 | $19,332 |
Total Patients
264
Total Services
1,055
Medicare Billing
$19,332
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 46 | $8,740 | $4,114 | 47.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 40 | $15,400 | $3,416 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 51 | $6,885 | $3,328 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,860 | $3,305 | 48.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $3,960 | $1,941 | 49.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 21 | 110 | $7,920 | $1,180 | 14.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 48 | 134 | $7,638 | $1,005 | 13.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 49 | 117 | $2,808 | $966.00 | 34.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 460 | $920.00 | $44.83 | 4.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 17 | 45 | $540.00 | $33.51 | 6.2% |
About Dr. Francis Bell, DO
Dr. Francis Bell, DO is a Internal Medicine healthcare provider based in Hattiesburg, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1912437310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Bell, DO has received a total of $6,186 in payments from pharmaceutical and medical device companies, with $2,829 received in 2024. These payments were reported across 282 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($5,986).
As a Medicare-enrolled provider, Bell has provided services to 264 Medicare beneficiaries, totaling 1,055 services with total Medicare billing of $19,332. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Hattiesburg, MS
- Active Since 06/18/2017
- Last Updated 03/28/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912437310
Products in Payments
- JAKAFI (Drug) $244.97
- DARZALEX (Biological) $244.25
- REBLOZYL (Biological) $234.60
- MONJUVI (Drug) $229.04
- OPDIVO (Biological) $198.95
- KEYTRUDA (Biological) $186.81
- CABOMETYX (Drug) $172.16
- ENHERTU (Biological) $169.64
- BRUKINSA (Drug) $137.29
- CALQUENCE (Drug) $124.26
- SARCLISA (Biological) $122.75
- Orserdu (Drug) $108.63
- Cresemba (Drug) $105.44
- IMBRUVICA (Drug) $99.19
- ICLUSIG (Drug) $98.97
- Trodelvy (Drug) $96.00
- KISQALI (Drug) $89.56
- Nplate (Biological) $76.51
- XTANDI (Drug) $75.36
- MONOFERRIC (Drug) $74.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hattiesburg
Dr. Diego Alcivar Franco, M.d, M.D
Internal Medicine — Payments: $40,759
Internal Medicine $40,759
Alexey Fomin, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $16,997
Internal Medicine $16,997
Michael Raggio, M.d, M.D
Internal Medicine — Payments: $12,170
Internal Medicine $12,170
Porter Glover, M.d, M.D
Internal Medicine — Payments: $10,813
Internal Medicine $10,813
Charles Hernandez, Do, DO
Internal Medicine — Payments: $10,522
Internal Medicine $10,522
Dr. Jacob Graham, M.d, M.D
Internal Medicine — Payments: $9,473
Internal Medicine $9,473